NCT06596148

Improving Shingrix Vaccination Among US Veterans Receiving Immunosuppression

VA Quality Improvement Research and Training Initiative

• Status: Enrolling By Invitation
• Phase: N/A
• Study type: Interventional
• Enrollment: 130 (estimated)
• Sponsor: University of California, San Francisco · Academic / Other
• Sex: All
• Age: —
• Healthy volunteers: Not accepted

Summary

The goal of this wait-list control trial is to learn if having access to a new dashboard displaying information about immunosuppressed Veterans missing vaccinations for Shingrix can improve Shingrix vaccination rates at VA facilities. The main question\[s\] it aims to answer is: Will vaccination rates improve more rapidly for facilities with access to the dashboard compare to facilities without access? VA facility personnel will be granted access to the dashboard and outcomes (vaccination rates) will be measured using electronic health record data.

Detailed description

Assignment of the intervention will occur at the facility level. Outcomes (vaccination) will be assessed for patients cared for at each facility.

Conditions

• Immunosuppresion

Interventions

Type	Name	Description
OTHER	Access to Shingrix dashboard	The investigators will build and grant access to a clinical dashboard that exists behind the VA firewall. The dashboard will identify Veterans from each VA facility who are receiving immunosuppressants (prescribed via the VA). The dashboard will also provide information about the number of Shingrix vaccines each patient has received (which have been documented within the VA electronic health record). VA clinicians will have access to view information about patients based on their VA electronic health record permissions.

Timeline

• Start date: 2024-09-16
• Primary completion: 2026-03-01
• Completion: 2026-06-30
• First posted: 2024-09-19
• Last updated: 2025-04-06

Locations

1 site across 1 country: United States